Anita Deswal, M.D., M.P.H.
Department of Medicine - Cardiology - Baylor College of Medicine
Associate Professor of Medicine, Baylor College of Medicine
Winters Center for Heart Failure Research
Office phone: 713-794-8625
Office fax: 713-748-7359
Dr. Deswal's principal research area of interest is heart failure, specifically, clinical trials and outcomes research in patients with heart failure. Her recent research has focused on studying the epidemiology and outcomes of patients with diastolic heart failure. She is currently conducting a single-center trial examining the role of aldosterone antagonism in the treatment of diastolic heart failure. Dr. Deswal's research also focuses on racial disparities and quality of care delivered to patients with heart failure. She is a member of National Executive Committee for the VA Chronic Heart Failure Quality Enhancement Research Initiative (CHF QUERI), an initiative of the Department of Veterans Affairs to improve the translation of findings from clinical trials into clinical practice.
Education and Training:
- Medical School: All India Institute of Medical Sciences, India
- Residency:University of Pittsburgh, Pittsburgh, PA
- Fellowship:University of Pittsburgh, Pittsburgh, PA
Area of Clinical Expertise:
- Singh H, Gordon H, Deswal A. Variation by Race in Factors Contributing to Heart Failure Hospitalizations. J Card Failure 2005;11:23-29
- Soltero E, Petersen NJ, Earl, Glaeser D, Urbauer D, Deswal A. Long-term results of coronary artery bypass grafting in patients with ischemic cardiomyopathy. J Card Failure. 2005;11:206-212.
- strong>Deswal, A. Diastolic Dysfunction and Diastolic Heart Failure: Mechanisms and Epidemiology. Current Cardiology Reports. 2005, 7:178-183
- Deswal A, Petersen NJ, Souchek J, Ashton CM, Wray NP. Impact of race on health care utilization and outcomes in veterans with congestive heart failure. J Am Coll Cardiol 2004;43:778-84.
- Agoston I, Cameron CS, Yao DZ, DeLa Rosa A, Mann DL, Deswal A. Comparison of Outcomes of White-vs-Black Patients Hospitalized with Heart Failure and Preserved Ejection Fraction. Am J Cardiol. 2004;94:1003-7.
- Mann DL, Deswal A. Angiotensin-Receptor Blockade in Acute Myocardial Infarction-A Matter of Dose. N Engl J Med 2003; 349:1963-1965.
- Deswal A, Bozkurt B, Seta Y, Parilti-Eiswirth S, Hayes AF, Blosch C, Mann DL: Safety and Efficacy of a Soluble p75 TNF Receptor (Enbrel, Etanercept) in patients with Advanced Heart Failure. Circulation, 1999; 99(25):3224-6